Biological response modifiers in cancer therapy

Keyphrases

• Administration Regimen 20%
• Antiangiogenic Properties 20%
• Anticancer Vaccines 40%
• Antigen Delivery 20%
• Biological Response Modifiers 100%
• Bleeding 20%
• Bone Marrow 20%
• Breast Cancer Treatment 20%
• Cancer Cells 20%
• Cancer Therapy 100%
• Carbohydrates 20%
• Chemotherapy 20%
• CSF-1 20%
• Delivery Vectors 20%
• DNA Encoding 20%
• DNA Sequencing 20%
• Growth Factors 20%
• Heat Shock Proteins 20%
• Host Immune Response 20%
• Immunostimulation 40%
• In Cancer 100%
• Inhibit Tumor 20%
• Interferon-α (IFN-α) 40%
• Interleukin 40%
• Interleukin-2 20%
• Kaposi Sarcoma 20%
• Leukemia 20%
• Malignant Melanoma 20%
• Metastatic Renal Cell Carcinoma (mRCC) 20%
• Monoclonal Antibody 40%
• Non-Hodgkin Lymphoma 20%
• Optimum Choice 20%
• Radiotherapy 20%
• Recent Advances 20%
• Recombinant Bacteria 20%
• Recombinant Virus 20%
• Rituximab 20%
• Scientific Use 20%
• Thalidomide 20%
• Trastuzumab 20%
• Tumor Angiogenesis 20%
• Tumor Cells 20%
• Tumor Immunology 20%
• Tumor Necrosis Factor-α 40%
• Tumor Proliferation 20%
• Tumor-specific 20%
• Vaccination 20%

Medicine and Dentistry

• Angiogenesis 20%
• Antiangiogenic 20%
• Biological Response Modifier 100%
• Bleeding 20%
• Breast Cancer 20%
• Cancer 40%
• Cancer Cell 20%
• Cancer Therapy 100%
• Colony Stimulating Factor 20%
• Cytokine 20%
• Growth Factor 20%
• Heat Shock Protein 20%
• Immune System 20%
• Immunostimulation 40%
• Infection 20%
• Interferon 40%
• Interleukin 2 20%
• Interleukin Derivative 20%
• Kaposi Sarcoma 20%
• Kidney Metastasis 20%
• Leukemia 20%
• Malignant Neoplasm 40%
• Melanoma 20%
• Monoclonal Antibody 40%
• Non-Hodgkin Lymphoma 20%
• Radiation Therapy 20%
• Rituximab 20%
• Specific Tumor 20%
• Thalidomide 20%
• Trastuzumab 20%
• Tumor Cell 20%
• Tumor Immunology 20%
• Tumor Necrosis 20%
• Tumor Necrosis Factor 20%
• Tumor Progression 20%
• Virus 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiangiogenic 20%
• Biological Response Modifier 100%
• Bleeding 20%
• Breast Cancer 20%
• Chemotherapy 20%
• Colony Stimulating Factor 20%
• Cytokine 20%
• Growth Factor 20%
• Heat Shock Protein 20%
• Infection 20%
• Interferon 40%
• Interleukin 2 20%
• Interleukin Derivative 20%
• Kaposi Sarcoma 20%
• Kidney Metastasis 20%
• Leukemia 20%
• Malignant Neoplasm 100%
• Melanoma 20%
• Monoclonal Antibody 40%
• Neoplasm 60%
• Nonhodgkin Lymphoma 20%
• Rituximab 20%
• Thalidomide 20%
• Trastuzumab 20%
• Tumor Growth 20%
• Tumor Necrosis 20%
• Tumor Necrosis Factor 20%